These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21073352)

  • 1. Targeting the embryonic gene Cripto-1 in cancer and beyond.
    Bianco C; Salomon DS
    Expert Opin Ther Pat; 2010 Dec; 20(12):1739-49. PubMed ID: 21073352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cripto-1 as a target for a cancer vaccine: WO2008040759.
    Bianco C; Salomon DS
    Expert Opin Ther Pat; 2009 Feb; 19(2):141-4. PubMed ID: 19441915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cripto monoclonal antibodies.
    Hu XF; Xing PX
    Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cripto-1: an embryonic gene that promotes tumorigenesis.
    de Castro NP; Rangel MC; Nagaoka T; Salomon DS; Bianco C
    Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Cripto-1 in stem cell maintenance and malignant progression.
    Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
    Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cripto as a target for cancer immunotherapy.
    Hu XF; Xing PX
    Expert Opin Ther Targets; 2005 Apr; 9(2):383-94. PubMed ID: 15934922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of Cripto-1 protein in development and target therapy of breast cancer].
    Lei T; Guo XJ; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):66-8. PubMed ID: 20388407
    [No Abstract]   [Full Text] [Related]  

  • 8. Cripto: a novel target for antibody-based cancer immunotherapy.
    Xing PX; Hu XF; Pietersz GA; Hosick HL; McKenzie IF
    Cancer Res; 2004 Jun; 64(11):4018-23. PubMed ID: 15173016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers.
    Sandomenico A; Ruvo M
    Curr Med Chem; 2019; 26(11):1994-2050. PubMed ID: 30207211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells.
    Normanno N; Tortora G; De Luca A; Pomatico G; Casamassimi A; Agrawal S; Mendelsohn J; Bianco AR; Ciardiello F
    Oncol Rep; 1999; 6(5):1105-9. PubMed ID: 10425310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection with a CRIPTO anti-sense plasmid suppresses endogenous CRIPTO expression and inhibits transformation in a human embryonal carcinoma cell line.
    Baldassarre G; Bianco C; Tortora G; Ruggiero A; Moasser M; Dmitrovsky E; Bianco AR; Ciardiello F
    Int J Cancer; 1996 May; 66(4):538-43. PubMed ID: 8635871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma.
    Witt K; Ligtenberg MA; Conti L; Lanzardo S; Ruiu R; Wallmann T; Tufvesson-Stiller H; Chambers BJ; Rolny C; Lladser A; Lundqvist A; Cavallo F; Kiessling R
    Cancer Immunol Res; 2018 Nov; 6(11):1417-1425. PubMed ID: 30143536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth.
    Ishii H; Zahra MH; Takayanagi A; Seno M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cripto: a tumor growth factor and more.
    Adamson ED; Minchiotti G; Salomon DS
    J Cell Physiol; 2002 Mar; 190(3):267-78. PubMed ID: 11857442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors.
    Spiller CM; Gillis AJ; Burnet G; Stoop H; Koopman P; Bowles J; Looijenga LH
    Mol Oncol; 2016 Apr; 10(4):526-37. PubMed ID: 26654129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.
    Wu Z; Li G; Wu L; Weng D; Li X; Yao K
    BMC Cancer; 2009 Sep; 9():315. PubMed ID: 19732464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ cell nuclear factor is a repressor of CRIPTO-1 and CRIPTO-3.
    Hentschke M; Kurth I; Borgmeyer U; Hübner CA
    J Biol Chem; 2006 Nov; 281(44):33497-504. PubMed ID: 16954206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma.
    Strizzi L; Abbott DE; Salomon DS; Hendrix MJ
    Cell Cycle; 2008 Jul; 7(13):1931-5. PubMed ID: 18604175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.